Diabetes Screening

Order the appropriate diabetes screening for you online, no insurance or doctor's ordered required. Ulta Lab Tests provides reliable blood work and secure testing, so order today!

  • Page
  • 1
  • of
  • 2
  • Total Rows
  • 35
Name Matches

The Cardio IQ™ Diabetes and ASCVD Risk Panel with Scores measures advanced cardiovascular and metabolic markers to evaluate risk for atherosclerotic cardiovascular disease and type 2 diabetes. This panel includes lipid analysis, glucose-related biomarkers, and inflammation indicators, helping assess cardiometabolic health. Results provide clinicians with detailed scoring to identify patterns that may influence prevention and long-term disease management.


The Cardio IQ™ Diabetes Risk Panel with Score combines advanced biomarker analysis to evaluate insulin resistance, lipid metabolism, and glycemic control. This panel generates a diabetes risk score that helps identify individuals at increased risk for type 2 diabetes and related cardiometabolic complications. It provides insight into metabolic health, supporting early intervention, lifestyle planning, and long-term disease management.


Blood
Blood Draw

Blood, Urine
Blood Draw, Urine Collection

Blood, Urine
Blood Draw, Urine Collection

 The Diabetes Prevention Program (DPP) Screening Panel is a critical tool in the early identification and management of prediabetes and diabetes. This panel utilizes targeted tests to evaluate an individual's blood sugar levels and their body's ability to process glucose over time. By accurately assessing these factors, the panel helps healthcare providers detect early signs of glycemic control issues, enabling timely intervention that can prevent the onset of diabetes or manage it effectively in its initial stages.
Blood
Blood Draw

The Diabetes Risk Panel with Score combines multiple biomarkers to assess risk of developing type 2 diabetes and related metabolic conditions. By evaluating glucose control, insulin resistance, lipid levels, and inflammation markers, this panel provides a personalized score that reflects overall metabolic health. Clinicians use it to help identify individuals at increased risk, support early intervention, and monitor long-term health.


Blood
Blood Draw

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Blood
Blood Draw
Also Known As: CBC Test, CBC with Differential and Platelets Test, CBC w/Diff and Platelets Test, Full Blood Count Test, Complete Blood Count Test

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Blood
Blood Draw
Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Hemoglobin A1c (HbA1c) Test measures average blood glucose over 2–3 months by detecting sugar attached to hemoglobin in red blood cells. It is used to diagnose diabetes, identify prediabetes, and monitor long-term blood sugar control. Doctors rely on the HbA1c test to evaluate treatment effectiveness, guide adjustments, and assess risk for complications, making it essential for diabetes care and metabolic health screening.

Blood
Blood Draw
Also Known As: A1c Test, HbA1c Test, Glycated Hemoglobin Test

Most Popular

The Glucose Test measures blood sugar levels to evaluate energy metabolism and screen for diabetes or prediabetes. Abnormal glucose may indicate hyperglycemia, hypoglycemia, or metabolic disorders. Doctors use this test during routine exams, to investigate symptoms like fatigue, excessive thirst, or frequent urination, and to monitor treatment for diabetes. It provides essential insight into how the body regulates blood sugar and overall metabolic health.

Blood
Blood Draw
Also Known As: Fasting Glucose Test, Fasting Blood Sugar Test

The Glucose Tolerance Test, 2 Specimens, 75g evaluates the body’s glucose metabolism by testing fasting and one-hour blood glucose levels after ingestion of a 75-gram glucose solution. It is an important diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. This test helps reveal early changes in insulin sensitivity and overall metabolic function.

Blood
Blood Draw
Also Known As: Glucose 2 Specimen Test, Glucose 2 Hour Test, 2 Specimen Glucose Test

The Glucose Tolerance Test, 3 Specimens, 75g evaluates blood sugar at fasting, 1-hour, and 2-hour intervals following a 75-gram glucose drink. It is a key diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. Measuring glucose response at multiple times allows clinicians to assess insulin function, detect early metabolic dysfunction, and better understand progression to diabetes.

Blood
Blood Draw
Also Known As: Glucose 3 Specimen Test, Glucose 2 Hour Test, Glucose 1 hour Test, 3 Specimen Glucose Test

The Glucose Tolerance Test, 4 Specimens evaluates blood glucose at fasting, 1-hour, 2-hour, and 3-hour intervals after a glucose drink. This test is an important tool for diagnosing or screening for prediabetes, type 2 diabetes, and impaired glucose metabolism. Measuring glucose response across multiple specimens provides valuable data on insulin function, carbohydrate handling, and overall metabolic health.

Blood
Blood Draw
Also Known As: Glucose 4 Specimen Test, Glucose 3 Hour Test, Glucose 1 and a Half Hour Test, 4 Specimen Glucose Test

The Glucose Tolerance Test, 5 Specimens evaluates glucose response at fasting, 1, 2, 3, and 4 hours after a standard glucose drink. By analyzing multiple specimens, it identifies impaired glucose tolerance, prediabetes, and type 2 diabetes. The test provides clinicians with extensive information on insulin function, glucose regulation, and the progression of metabolic disorders that affect long-term health outcomes.

Blood
Blood Draw
Also Known As: Glucose 5 Specimen Test, Glucose 4 Hour Test, Glucose 2 hour Test, 5 Specimen Glucose Test

The Glucose Tolerance Test, 6 Specimens evaluates blood sugar response at fasting and hourly intervals up to 5 hours after ingestion of a glucose solution. This test provides a comprehensive assessment of glucose metabolism, helping detect impaired glucose tolerance, prediabetes, and diabetes risk. Measuring six specimens reveals detailed patterns of insulin function, metabolic regulation, and progression to chronic disease.

Blood
Blood Draw
Also Known As: Glucose 6 Specimen Test, Glucose 5 Hour Test, Glucose 2 and half hour Test, 6 Specimen Glucose Test

The Glucose Tolerance Test, 7 Specimens evaluates blood sugar at fasting and six hourly intervals after ingestion of a glucose solution, spanning 6 hours of monitoring. It is used to identify prediabetes, diabetes, and impaired glucose regulation. By analyzing seven specimens, the test reveals patterns in insulin function, metabolic regulation, and progression of abnormalities that impact long-term health.

Blood
Blood Draw
Also Known As: Glucose 7 Specimen Test, Glucose 6 Hour Test, Glucose 3 Hour Test, 7 Specimen Glucose Test

The Gestational Glucose Tolerance Test, 3 Specimens, 75g evaluates glucose metabolism during pregnancy by testing fasting, 1-hour, and 2-hour blood glucose following a 75-gram glucose solution. It is widely used to diagnose gestational diabetes and assess maternal insulin function. Monitoring three intervals provides clinicians with essential information about pregnancy-related metabolic health and risk factors.

Blood
Blood Draw

The Gestational Glucose Tolerance Test, 4 Specimens, 100g evaluates maternal blood sugar response at fasting, 1, 2, and 3 hours following a 100-gram glucose drink. It is widely used to detect gestational diabetes and impaired glucose regulation in pregnancy. By assessing four time points, the test delivers valuable data on insulin activity, maternal metabolism, and risks that may affect both mother and baby.

Blood
Blood Draw

Blood
Blood Draw

The Fasting and Gestational Glucose Test, 135 Cutoff evaluates fasting glucose and post-load blood sugar one hour after a 50-gram glucose challenge. A 135 mg/dL cutoff helps identify women at increased risk for gestational diabetes who may require follow-up testing. This test offers valuable information about maternal carbohydrate metabolism, insulin activity, and abnormal glucose regulation in pregnancy.


The Fasting and Gestational Glucose Test, 140 Cutoff evaluates both fasting glucose and blood sugar one hour after a 50-gram glucose drink. A result above the 140 mg/dL cutoff identifies women at risk for gestational diabetes who may need follow-up testing. This screening tool highlights maternal carbohydrate metabolism, insulin activity, and abnormal glucose regulation during pregnancy.

Blood
Blood Draw

 The 2 Hour Fasting and Postprandial Glucose Test is a diagnostic procedure that measures the body's ability to metabolize glucose (sugar) and respond to insulin. It involves taking two blood samples: one after an overnight fast and another two hours after consuming a meal.
Blood
Blood Draw

The Gestational Glucose Screen, 50g, 135 Cutoff evaluates maternal blood sugar one hour after a 50-gram glucose drink to screen for gestational diabetes risk. A threshold of 135 mg/dL helps determine the need for follow-up glucose tolerance testing. This test offers important information on maternal carbohydrate metabolism, insulin function, and potential complications related to abnormal glucose regulation in pregnancy.


When you have glucose levels that are above normal, but not as high as to be diagnosed as a diabetic, you are probably suffering from prediabetes, also called impaired glucose tolerance or impaired fasting glucose. Data released by the Centers for Disease Control and Prevention recently have indicated that in the U.S. alone, during the year 2012, 86 million adults were suffering from prediabetes. Normally, people who have prediabetes do not exhibit any symptoms, but if no action is taken to reduce their glucose levels, they increasingly risk developing diabetes within the next decade of their lives. 

The United States Preventive Services Task Force, as well as the American Diabetes Association (ADA), recommends that all adults who are 45 years or more be screened for diabetes, as well as those overweight adults who are below 45 years, and have additional risk factors that could lead to type 2 diabetes. 

These risk factors are: 

  • Those who are physically inactive, obese and overweight 
  • Those who have a first-degree close relative that suffers from diabetes 
  • Women who have delivered children of more than 9 pounds weight and earlier suffered from gestational diabetes 
  • Women with PCOS (polycystic ovary syndrome) 
  • Those of a race or ethnicity that is considered high-risk, like Pacific Islanders, Asian Americans, Native Americans, Latino, or African Americans. 
  • People who have hypertension or high blood pressure and are taking medications for it 
  • Patients with less than 35 mg/dL or 0.90 mmol/L HDL cholesterol, and/or those with a high triglyceride level which is more than 2.82 mmol/L or 250 mg/dL 
  • If you have an A1C level above or equal to 5.7 or have been identified as prediabetic by any previous screenings 

Signs and Symptoms 

At the time of diagnosis, those with prediabetes may not exhibit any definite signs or symptoms of diabetes. 

Laboratory Tests 

The objective of any testing for diabetes is to screen patients with hyperglycemia or high blood glucose levels so that diabetes or prediabetes can be detected and diagnosed. Testing also helps in monitoring and controlling the levels of glucose over a period of time and can help in detecting and monitoring any complications. 

Tests can be used: 

  • When a person exhibits signs and symptoms that indicate diabetes 
  • When a person has other risk factors or conditions that are normally associated with diabetes 
  • When persons with an acute condition report to emergency rooms 
  • Regular testing for glucose control and monitoring diabetes 

Diabetes can occur during pregnancy, and screening for gestational diabetes at this time is different from the testing adopted for the general population. More information available in the section on Gestational Diabetes 

The American Diabetes Association suggests several different tests to screen and diagnose diabetes or prediabetes, and every one of these tests has its limitations, advantages, and disadvantages. If abnormal results are obtained from any of the tests listed below, then the tests are carried out again another day. For confirming a diagnosis of diabetes, the repeated result must show the same degree of abnormality.

Tests include: 

Fasting Glucose Level:

Indications:  

  • 70 to 99 mg/dL (3.9 to 5.5 mmol/L) indicates normal fasting glucose 
  • 100 to 125 mg/dL (5.6 to 6.9 mmol/L) indicates prediabetes or impaired fasting glucose 
  • Equal to and above 126 mg/dL (7.0 mmol/L) a result, repeated more than once indicates diabetes 

A1c test, also called glycohemoglobin or hemoglobin A1c, is a test that indicates the average amount of glucose for the previous 2 to 3 months. For this test, there is no need for patients to fast for 8 hours, or have multiple blood samples taken, but it is not a test that is meant for everyone. It should not be used for diagnosing diabetes in women who are pregnant, those who have recently suffered heavy bleeding or received blood transfusions, people with chronic diseases of the liver or kidney, people with blood disorders like anemia for iron deficiency, vitamin B12, and other hemoglobin variants. A1c tests should be used for screening or diagnosis if they have been standardized to acceptable laboratory standards. In the present day, point-of-care tests that are used in doctor’s offices or at the bedside of a patient vary a lot and are not useful for diagnosis, though they can be used for monitoring treatment, lifestyles, and drug therapies. 

A1c level Indications:

  • 5.7% (39 mmol/mol) or less is considered normal 
  • 5.7% to 6.4% (39-46 mmol/mol) indicates prediabetes 
  • 6.5% (47 mmol/mol) or higher indicates diabetes 

OGTT is a 2-hour test for glucose tolerance. In this test, blood is drawn after fasting and followed by the patient drinking a 75-gram glucose drink. A blood sample is again drawn two hours after the glucose is consumed. 

Glucose Level 2 hours after the 75-gram drink Indication  

  • 140 mg/dL (7.8 mmol/L) or less indicates normal glucose tolerance 
  • 140 to 199 mg/dL (7.8 to 11.1 mmol/L) indicates impaired glucose tolerance or prediabetes 
  • 200 mg/dL (11.1 mmol/L) or more results, when tested more than once, indicates diabetes 

Blood samples are sometimes drawn for measuring glucose even when the person has not been fasting, often for a CMP or comprehensive metabolic panel. Results here that are 200 mg/dL (11.1 mmol/L) or higher are an indication of diabetes. Abnormal results must always be followed up with an additional test.  

Besides these diabetes tests that have been detailed above, there can also be other tests used to screen, diagnose, monitor, and evaluate for type 2 diabetes. 

Diabetes autoantibodies – this test helps in distinguishing between the two types of diabetes, Type 1 and Type 2, when the diagnosis is otherwise not clear. When one or more antibodies are detected, this confirms Type 1 diabetes. 

Insulin, C peptide – this test monitors the production of insulin. 

Lab Testing Helps in Diagnosing Prediabetes 

When you have glucose levels that are above normal, but not as high as to be diagnosed as a diabetic, you are probably suffering from prediabetes, also called impaired glucose tolerance or impaired fasting glucose. Data released by the Centers for Disease Control and Prevention recently have indicated that in the U.S. alone, during the year 2012, 86 million adults were suffering from prediabetes. Normally, people who have prediabetes do not exhibit any symptoms, but if no action is taken to reduce their glucose levels, they increasingly risk developing diabetes within the next decade of their lives. 

The United States Preventive Services Task Force, as well as the American Diabetes Association (ADA), recommends that all adults who are 45 years or more be screened for diabetes, as well as those overweight adults who are below 45 years, and have additional risk factors that could lead to type 2 diabetes. 

These risk factors are: 

Those who are physically inactive, obese and overweight 

Those who have a first-degree close relative that suffers from diabetes 

Women who have delivered children of more than 9 pounds weight and earlier suffered from gestational diabetes 

Women with PCOS (polycystic ovary syndrome) 

Those of a race or ethnicity that is considered high-risk, like Pacific Islanders, Asian Americans, Native Americans, Latino, or African Americans. 

People who have hypertension or high blood pressure and are taking medications for it 

Patients with less than 35 mg/dL or 0.90 mmol/L HDL cholesterol, and/or those with a high triglyceride level which is more than 2.82 mmol/L or 250 mg/dL 

If you have an A1C level above or equal to 5.7 or have been identified as prediabetic by any previous screenings 

Signs and Symptoms 

At the time of diagnosis, those with prediabetes may not exhibit any definite signs or symptoms of diabetes. 

Laboratory Tests 

The objective of any testing for diabetes is to screen patients with hyperglycemia or high blood glucose levels so that diabetes or prediabetes can be detected and diagnosed. Testing also helps in monitoring and controlling the levels of glucose over a period of time and can help in detecting and monitoring any complications. 

Tests can be used: 

  • When a person exhibits signs and symptoms that indicate diabetes 
  • When a person has other risk factors or conditions that are normally associated with diabetes 
  • When persons with an acute condition report to emergency rooms

Diabetes can occur during pregnancy, and screening for gestational diabetes at this time is different from the testing adopted for the general population. More information available in the section on Gestational Diabetes 

The American Diabetes Association suggests several different tests to screen and diagnose diabetes or prediabetes, and every one of these tests has its limitations, advantages, and disadvantages. If abnormal results are obtained from any of the tests listed below, then the tests are carried out again another day. For confirming a diagnosis of diabetes, the repeated result must show the same degree of abnormality. Tests include: 

Fasting Glucose Level: Indications:  

  • 70 to 99 mg/dL (3.9 to 5.5 mmol/L) indicates normal fasting glucose 
  • 100 to 125 mg/dL (5.6 to 6.9 mmol/L) indicates prediabetes or impaired fasting glucose 
  • Equal to and above 126 mg/dL (7.0 mmol/L) a result, repeated more than once indicates diabetes 

A1c test, also called glycohemoglobin or hemoglobin A1c, is a test that indicates the average amount of glucose for the previous 2 to 3 months. For this test, there is no need for patients to fast for 8 hours, or have multiple blood samples taken, but it is not a test that is meant for everyone. It should not be used for diagnosing diabetes in women who are pregnant, those who have recently suffered heavy bleeding or received blood transfusions, people with chronic diseases of the liver or kidney, people with blood disorders like anemia for iron deficiency, vitamin B12, and other hemoglobin variants. A1c tests should be used for screening or diagnosis if they have been standardized to acceptable laboratory standards. In the present day, point-of-care tests that are used in doctor’s offices or at the bedside of a patient vary a lot and are not useful for diagnosis, though they can be used for monitoring treatment, lifestyles, and drug therapies. 

A1c level Indications 

  • 5.7% (39 mmol/mol) or less is considered normal 
  • 5.7% to 6.4% (39-46 mmol/mol) indicates prediabetes 
  • 6.5% (47 mmol/mol) or higher indicates diabetes 

OGTT is a 2-hour test for glucose tolerance. In this test, blood is drawn after fasting and followed by the patient drinking a 75-gram glucose drink. A blood sample is again drawn two hours after the glucose is consumed. 

Glucose Level 2 hours after the 75-gram drink Indication  

  • 140 mg/dL (7.8 mmol/L) or less indicates normal glucose tolerance 
  • 140 to 199 mg/dL (7.8 to 11.1 mmol/L) indicates impaired glucose tolerance or prediabetes 
  • 200 mg/dL (11.1 mmol/L) or more results, when tested more than once, indicates diabetes 

Blood samples are sometimes drawn for measuring glucose even when the person has not been fasting, often for a CMP or comprehensive metabolic panel. Results here that are 200 mg/dL (11.1 mmol/L) or higher are an indication of diabetes. Abnormal results must always be followed up with an additional test.  

Besides these diabetes tests that have been detailed above, there can also be other tests used to screen, diagnose, monitor, and evaluate for type 2 diabetes. 

Diabetes autoantibodies – this test helps in distinguishing between the two types of diabetes, Type 1 and Type 2, when the diagnosis is otherwise not clear. When one or more antibodies are detected, this confirms Type 1 diabetes. 

Insulin, C peptide – this test monitors the production of insulin. 

Urine and/or Blood Ketone Tests are often ordered for those patients who come to emergency rooms with indications of acute hyperglycemia, to those who need monitoring because they are being treated for ketoacidosis. Ketone buildup occurs when the effectiveness of the insulin or its amount decreases in the body.